ReviewFrontiers in endocrinology2023
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.
Yuejun Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it
ReviewFrontiers in endocrinology2023
Yuejun Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.